Benjamin P. Linas, MD

Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Linas is a national leader in hepatitis-C virus (HCV) infection and HCV/HIV co-infection comparative- and cost-effectiveness research using computational biology, clinical epidemiology and clinical economics methods. Dr. Linas has an excellent track record of productivity, ample funding from the NIH and CDC, and a growing core of successful trainees. Dr. Linas directs the HIV/HCV core of the Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV, funded by the National Institute on Drug Abuse (NIDA) in collaboration with Cornell, U Penn and Miami.

Publications

  • Published 5/1/2025

    Curtis MR, Munroe S, Biondi BE, Ciaranello AL, Linas BP, Epstein RL. Disparities in Linkage to Care Among Children With Hepatitis C Virus in the United States. Pediatrics. 2025 May 01; 155(5). PMID: 40246302.

    Read at: PubMed

  • Published 4/21/2025

    Linas BP, Weitz M, Pramanick T, Sulkowski M, Smeaton LM, Cardoso SW, Solomon S. Health economic outcomes of a minimal monitoring approach to providing HCV therapy. Hepatol Commun. 2025 May 01; 9(5). PMID: 40257357.

    Read at: PubMed

  • Published 4/17/2025

    Barocas JA, Aldridge A, Adkins KF, Barbosa C, Battaglia TA, Bush J, Castry M, Corry G, Clarke T, El-Bassel N, Figueroa W, Freedman DA, Freisthler B, Gibbons B, Gibson EB, Glasgow L, Harlow K, Huerta TR, Hunt T, Johnson R, Larimore E, Linas BP, Luckey JM, Montoya I, Murphy SM, Oga E, Onuoha E, Orme S, Ryan D, Schackman BR, Seiber EE, Singer M, Speer D, Starbird L, Tin Y, Villani J, Walsh SL, Watson C, Zarkin GA, McCollister K. An economic analysis of community costs incurred to implement the communities that HEAL intervention to reduce opioid overdose deaths in four states. Drug Alcohol Depend. 2025 Jul 01; 272:112671. PMID: 40311556.

    Read at: PubMed

  • Published 4/15/2025

    Singh RP, Biondi B, Gordon SH, Linas BP, Epstein RL. Hepatitis C Virus Screening in Pregnant and Nonpregnant Women After Universal Screening Guidelines. JAMA. 2025 Apr 15; 333(15):1356-1358. PMID: 39992633.

    Read at: PubMed

  • Published 3/27/2025

    Madushani RWMA, Wang J, Weitz M, Linas BP, White LF, Chrysanthopoulou SA. Empirical calibration of a simulation model of opioid use disorder. PLoS One. 2025; 20(3):e0310763. PMID: 40146669.

    Read at: PubMed

View All 191 Publications:   View Full Profile in BUMC

Other Positions

  • Professor, Epidemiology
    Boston University School of Public Health

Websites

Education

  • New York University School of Medicine, MD
  • Harvard School of Public Health, MPH
  • Yale University, BA

View all profiles